1,513
Views
2
CrossRef citations to date
0
Altmetric
Odyssey of Diabetes & Metabolic Disease

Are we there yet? Increasing use of cardioprotective antihyperglycemic agents in patients with T2D and CVD or CV risk in the United States

, , , &
Pages 1785-1795 | Received 11 Mar 2022, Accepted 01 Jun 2022, Published online: 27 Jun 2022

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.